Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination

Multiple Sclerosis

Volumn 3, Issue 2, 1997, Pages 76-79

  Van Engelen, Baziel G M ^a,b,c   Pavelko, Kevin D ^a,b   Rodriguez, Moses ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CNS; Demyelination; Experimental models; Humans; Immunoglobulin; Remyelination

Indexed keywords

IMMUNOGLOBULIN;

CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DEMYELINATION; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; HUMAN; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; REMYELINIZATION;

EID: 0030750808     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859700300203     Document Type: Conference Paper

References (39)

1. Blakemore WF. (1973) Demyelination in the superior cerebellar peducle in the mouse induced by Cuprizone. J Neurol Sci 20: 63-72.
2. Yajima K, Suzuki K. (1979) Demyelination and remyelination in the rat central nervous system following ethidium bromide injection. Lab Invest 41: 385-392.
3. Hall SM. (1972) The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J Cell Sci 13: 257-277.
4. Raine CS, Traugott U. (1985) Remyelination in chronic relapsing experimental allergic encephalomyelitis and multiple sclerosis. In: The pathology of myelinated axon (Adachi M, Hirano A, Aronson SM, (eds). New York: Igaku-Shoin, 229-275.
5. Herndon RM, Price DP, Weiner LP. (1977) Regeneration of oligodendroglia during recovery from demyelinating disease. Science 195: 693-694.
6. Rodriguez M, Lennon VA. (1990) Immunoglobulins promote remyelination in the central nervous system. Ann Neurol 27: 12-17.
7. Prineas JW, Connell F. (1979) Remyelination in multiple sclerosis. Ann Neurol 5: 22-31.
8. Rodriguez M, Sheithauer B. (1994) Ultrastructure of multiple sclerosis. Ultrastruct Pathol 18: 3-13.
9. Ghatak NR, Hirano A, Doron Y, Zimmerman HM. (1973) Remyelination in multiple sclerosis with peripheral type myelin. Arch Neurol 29: 262-267.
10. Rodriguez M, Lindsley MD. (1992) Immunosuppression promotes CNS remyelination in chronic virus-induced demyelinating disease. Neurology 42: 348-357.
11. Rodriguez M, Lennon VA, Benveniste EN, Merrill JE. (1987) Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J Neuropath Exp Neurol 46: 84-95.
12. Van Engelen BGM, et al. (1995) Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis. J Neurol Neurosurg Psychiatry 57: 65-68.
13. Miller DJ, Sanborn KS, Katzman JA, Rodriguez M. (1994) Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 14: 6230-6238.
14. Achiron A, et al. (1994) Intravenous immunoglobulin treatment of experimental T-cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion. J Clin Invest 93: 600-605.
15. Trotter JL, van der Veen RC. (1991) Autoantibodies in multiple sclerosis. In: Handbook of multiple sclerosis Cook SD, (ed.) New York: Marcel Dekker, 151-168.
16. Grundke-Iqbal I, Bornstein MB. (1980) Multiple sclerosis: serum gamma globulin and demyelination in organ culture. Neurology 30: 749-754.
17. Link H, Baikg S, Kostulas V, Olsson O, Olsson T. (1989) Immunoglobulin-secreting cells in the cerebrospinal fluid from patients with tension headache. J Neuroimmunol 25: 1-6.
18. Walsh MJ, Tourtelotte WW. (1986) Temporal invariance and clonal uniformity of brain and CSF IgG, IgA, and IgM in multiple slerosis. J Exp Med 163: 41-53.
19. Rostrom B. (1981) Specificity of antibodies in oligoclonal bands in patients with multiple sclerosis and cerebrovascular disease. Acta Neurol Scand 63: 1-84.
20. Matsiota P, et al. (1988) Comparative study of natural autoantibodies in the serum and cerebrospinal fluid of normal individuals and patients with multiple sclerosis and other neurological diseases. Ann Immunol (Inst Pasteur 139: 99-108.
21. Raine CS, Moore GRW, Hintzen R, Traugott U. (1988) Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Lab Invest 59: 467-476.
22. Grabar P. (1983) Autoantibodies and the physiological role of immunoglobulins. Immunol Today 4: 337-340.
23. Coutinho A. (1989) Beyond clonal selection and network. Immunol Review 110: 63-87.
24. Kerlero de Rosbo N, Honegger P, Lassmann H, Matthieu JM. (1990) Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin oligodendrocyte glycoprotein. J Neurochem 55: 583-587.
25. Mastaglia FL, Carroll WM, Jennings AR. (1989) Spinal cord lesions induced by antigalactocerebroside serum. Clin Exp Neurol 26: 33-44.
26. Raine CS, Diaz M, Pakingan M, Bomstein MB. (1978) Anti-serum induced dissociation of myelinogenesis in vitro: an ultrastructural study. Lab Invest 38: 397-403.
27. Bansal R, Gard AL, Pfeiffer SE. (1988) Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid. J Neurosci Res 21: 260-267.
28. Rodriguez M. (1991) Immunoglobulins stimulate central nervous system remyelination: electron microscopic and morphometric analysis of proliferating cells. Lab Invest 64: 358-370.
29. Berneman A, Ternynck T, Avramas S. (1992) Natural mouse IgG reacts with self antigens including molecules involved in the immune response. Eur J Immunol 22: 625-633.
30. van Engelen BGM, et al. (1992) Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis. Ann Neurol 32: 835-836.
31. Blakemore WF. (1973) Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding Cuprizone. J Neurol Sci 20: 73-83.
32. Ludwin SK. (1988) Remyelination in the central nervous system and the peripheral nervous system. Adv Neurol 47: 215-254.
33. Moll C, Mourre C, Lazdunski M, Ulrich J. (1991) Increase of sodium channels in demyelinated lesions of multiple sclerosis. Brain Res 556: 311-316.
34. Casteels-Van Daele M, Wijndale L, Hunninck K. (1990) Intravenous immune globulin and acute aseptic meningitis. N Engl J Med 323: 614-615.
35. Eeg-Olofsson O, Link H, Wigertz A. (1981) Concentrations of CSF proteins as a measure of blood brain barrier function and synthesis of IgG within the CSN in 'normal' subjects from the age of 6 months to 30 years. Acta Pediatr Scand 70: 167-170.
36. Cutler RWP, Watters GW, Hammerstad JP, Merler E. (1967) Origin of cerebrospinal fluid gammaglobulin in subacute sclerosing leukoencephalitis. Arch Neurol 17: 620-628.
37. 131-markiertem gamma-globulin zur Frage der Abstammung der Liquoreiweisskoerper. Klin Wochenschr 36: 857-863.
38. Tourtelotte WW, et al. (1980) Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate. Neurology 30: 240-244.
39. Miller DJ, Rodriguez M. (1995) A monoclonal antibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes. J Immunol 154: 2640-2649.